Molly Joel Coye - Net Worth and Insider Trading
Molly Joel Coye Net Worth
The estimated net worth of Molly Joel Coye is at least $1 Million dollars as of 2024-11-13. Molly Joel Coye is the Director of Aetna Inc and owns about 6,637 shares of Aetna Inc (AET) stock worth over $1 Million. Details can be seen in Molly Joel Coye's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Molly Joel Coye has not made any transactions after 2017-05-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Molly Joel Coye
Molly Joel Coye Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Molly Joel Coye owns 3 companies in total, including Amedisys Inc (AMED) , Aetna Inc (AET) , and Khosla Ventures Acquisition Co (KVSA) .
Click here to see the complete history of Molly Joel Coye’s form 4 insider trades.
Insider Ownership Summary of Molly Joel Coye
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AMED | Amedisys Inc | 2021-06-08 | director |
| AET | Aetna Inc | 2018-11-28 | director |
| KVSA | Khosla Ventures Acquisition Co | 2021-03-03 | director |
Molly Joel Coye Latest Holdings Summary
Molly Joel Coye currently owns a total of 1 stock. Molly Joel Coye owns 6,637 shares of Aetna Inc (AET) as of May 9, 2017, with a value of $1 Million.
Molly Joel Coye Form 4 Trading Tracker
According to the SEC Form 4 filings, Molly Joel Coye has made a total of 0 transactions in Aetna Inc (AET) over the past 5 years. The most-recent trade in Aetna Inc is the sale of 880 shares on May 9, 2017, which brought Molly Joel Coye around $125,118.
Insider Trading History of Molly Joel Coye
- 1
Molly Joel Coye Trading Performance
GuruFocus tracks the stock performance after each of Molly Joel Coye's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Molly Joel Coye is 5.79%. GuruFocus also compares Molly Joel Coye's trading performance to market benchmark return within the same time period. The performance of stocks bought by Molly Joel Coye within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Molly Joel Coye's insider trading performs compared to the benchmark.
Performance of Molly Joel Coye
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.32 | | | | | |
| Relative Return to S&P 500(%) | 3.22 | | | | | |
Molly Joel Coye Ownership Network
Ownership Network List of Molly Joel Coye
Ownership Network Relation of Molly Joel Coye
Molly Joel Coye Owned Company Details
What does Amedisys Inc do?
Who are the key executives at Amedisys Inc?
Molly Joel Coye is the director of Amedisys Inc. Other key executives at Amedisys Inc include Chief Accounting Officer Allyson Guidroz , director & President and CEO Richard M Ashworth , and Chief Information Officer Michael Paul North .
Amedisys Inc (AMED) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Amedisys Inc (AMED) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Amedisys Inc (AMED) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Amedisys Inc (AMED)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amedisys Inc Insider Transactions
Molly Joel Coye Mailing Address
Above is the net worth, insider trading, and ownership report for Molly Joel Coye. You might contact Molly Joel Coye via mailing address: Aetna Inc, 151 Farmington Avenue, Hartford Ct 06156.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
